C.G. Chapman

2.3k citations

25 papers · 1.9k indexed · 1 hit paper · h-index 15

Molecular Biology top 10%
Physiology top 2%
Cellular and Molecular Neuroscience top 5%
Pharmacology top 2%
Computational Theory and Mathematics top 2%

Co-authors: Israel Gloger H.J. Meadows Gary Christie Thomas D. Meek David L. Simmons David G. Tew David J. Powell Ishrut Hussain
Topics: Neuroscience and Neuropharmacology Research (8 papers)Ion channel regulation and function (8 papers)Blood Coagulation and Thrombosis Mechanisms (5 papers)
Cited by: Physiology Cellular and Molecular Neuroscience Pharmacology
Journals: Nucleic Acids Research Journal of Biological Chemistry Circulation
Partner nations: United Kingdom United States Switzerland

In The Last Decade

C.G. Chapman

25 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

1999 887 citations Ishrut Hussain, David J. Powell et al. Molecular and Cellular Neuroscience profile →

Peers

Countries citing papers authored by C.G. Chapman

Since Specialization

Citations

This map shows the geographic impact of C.G. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.G. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.G. Chapman more than expected).

Fields of papers citing papers by C.G. Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.G. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.G. Chapman. The network helps show where C.G. Chapman may publish in the future.

Co-authorship network of co-authors of C.G. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of C.G. Chapman. A scholar is included among the top collaborators of C.G. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.G. Chapman. C.G. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection 2003 ·The Journal of Physiology ·(unknown),Paul J. Kemp,Anthony Lewis,C.G. Chapman,H.J. Meadows,Chris Peers	47
2	The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK 2001 ·Brain Research ·H.J. Meadows,C.G. Chapman,D. Malcolm Duckworth,Rosemary E. Kelsell,Paul R. Murdock,S. Nasir,(unknown),Andrew D. Randall	47
3	Recombinant hTASK1 Is an O2-Sensitive K+ Channel 2001 ·Biochemical and Biophysical Research Communications ·Anthony Lewis,Matthew E. Hartness,C.G. Chapman,Ian M. Fearon,H.J. Meadows,Chris Peers,Paul J. Kemp	64
4	Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery 2001 ·Molecular Brain Research ·Andrew D. Medhurst,(unknown),C.G. Chapman,H.J. Meadows,(unknown),Rosemary E. Kelsell,Israel Gloger,Menelas N. Pangalos	252
5	Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channel 2000 ·Molecular Brain Research ·C.G. Chapman,H.J. Meadows,(unknown),David A. Campbell,Malcolm Duckworth,Rosemary E. Kelsell,Paul R. Murdock,Andrew D. Randall,(unknown),Israel Gloger	77
6	Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel 2000 ·Pflügers Archiv - European Journal of Physiology ·H.J. Meadows,Christopher D. Benham,William Cairns,Israel Gloger,Cameron V. Jennings,Andrew D. Medhurst,Paul R. Murdock,C.G. Chapman	83
7	ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site 2000 ·Molecular and Cellular Neuroscience ·Ishrut Hussain,David J. Powell,David Howlett,Gayle A. Chapman,(unknown),Paul R. Murdock,David G. Tew,Thomas D. Meek,C.G. Chapman,Klaus Schneider,(unknown),Daniel Tattersall,(unknown),Christopher Southan,D. M. Ryan,David L. Simmons,F S Walsh,C. Dingwall,Gary Christie	131
8	Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel 2000 ·Pflügers Archiv - European Journal of Physiology ·H.J. Meadows,Christopher D. Benham,William Cairns,Israel Gloger,Cameron V. Jennings,Andrew D. Medhurst,Paul R. Murdock,C.G. Chapman	22
9	Cloning, functional characterisation and population analysis of a variant form of the human glycine type 2 transporter 1999 ·FEBS Letters ·Joanne Evans,Hugh J. Herdon,William Cairns,E. A. O’Brien,C.G. Chapman,Jonathan Terrett,Israel Gloger	9
10	Identification of a Novel Aspartic Protease (Asp 2) as β-Secretasebreakdown → 1999 ·Molecular and Cellular Neuroscience ·Ishrut Hussain,David J. Powell,David Howlett,David G. Tew,Thomas D. Meek,C.G. Chapman,Israel Gloger,(unknown),Christopher Southan,Dominic M. Ryan,(unknown),David L. Simmons,Frank S. Walsh,Colin Dingwall,Gary Christie	887
11	The putative 116 kDa osteoclast specific vacuolar proton pump subunit has ubiquitous tissue distribution 1998 ·European Journal of Pharmacology ·Boyd B. Scott,C.G. Chapman	15
12	Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Shelagh Wilson,(unknown),(unknown),Andreas G. Ladurner,David Cronk,C.G. Chapman,(unknown),Molly Browne,Gerard J. Murphy,Paul Young	49
13	A Novel Family of Cathepsin L-like (CTSLL) Sequences on Human Chromosome 10q and Related Transcripts 1994 ·Genomics ·S Bryce,Susan Lindsay,(unknown),K. S. Braithwaite,C.G. Chapman,N.K. Spurr,John Lunec	11
14	A recombinant, chimeric enzyme with a novel mechanism of action leading to greater potency and selectivity than tissue-type plasminogen activator. 1992 ·Circulation ·J.H. Robinson,Molly Browne,J.E. Carey,(unknown),C.G. Chapman,David Cronk,Ian B. Dodd,Claire Entwisle,(unknown),S. Barret Kalindjian	7
15	Expression of recombinant human plasminogen and aglycoplasminogen in hela cells 1991 ·Fibrinolysis and Proteolysis ·Molly Browne,C.G. Chapman,Ian B. Dodd,J.E. Carey,G. M. Lawrence,(unknown),J.H. Robinson	3
16	Isolation of the human ml (Hml) muscarinic acetylcholine receptor gene by PCR amplification 1990 ·Nucleic Acids Research ·C.G. Chapman,Michael Browne	10
17	Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulation 1990 ·Thrombosis Research ·Molly Browne,C.G. Chapman,Ian B. Dodd,(unknown),J.H. Robinson	13
18	The role of tissue-type plasminogen activator A-chain domains in plasma clearance 1989 ·Fibrinolysis and Proteolysis ·Molly Browne,C.G. Chapman,Ian B. Dodd,B. Reavy,(unknown),J.H. Robinson	13
19	Increased Yield of Human Tissue-Type Plasminogen Activator Obtained by Means of Recombinant DNA Technology 1985 ·Thrombosis and Haemostasis ·Molly Browne,Ian B. Dodd,J.E. Carey,C.G. Chapman,J.H. Robinson	21
20	Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cells 1985 ·Gene ·Molly Browne,A. W. R. TYRRELL,C.G. Chapman,J.E. Carey,David M. Glover,Frank Grosveld,Ian B. Dodd,J.H. Robinson	27

About C.G. Chapman

C.G. Chapman is a scholar working on Cellular and Molecular Neuroscience, Hematology and Cancer Research, having authored 25 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (8 papers), Ion channel regulation and function (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). The work is most often cited by research in Physiology (1.0k citations), Cellular and Molecular Neuroscience (495 citations) and Pharmacology (368 citations). C.G. Chapman has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Israel Gloger, H.J. Meadows, Gary Christie, Thomas D. Meek, David L. Simmons, David G. Tew, David J. Powell, Ishrut Hussain, Christopher Southan and David Howlett. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact